Keywords: CR، پاسخ کامل; APC, antigen-presenting cell; ATP, adenosine triphosphate; BRCA2, breast cancer susceptibility gene 2; CR, complete response; CTLA-4, cytotoxic T lymphocyte-associated antigen 4; CSF1R, colony-stimulating factor 1 receptor; CTL, cytotoxic T lymphocyte; DC
مقالات ISI CR، پاسخ کامل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CR، پاسخ کامل; testicular neoplasms; lymph node excision; bleomycinBEP, bleomycin, etoposide, cisplatin; CR, complete response; EP, etoposide, cisplatin; GCT, germ cell tumors; IGCCCG, International Germ Cell Cancer Collaborative Group; IU, Indiana University; PC-RPLND,
Keywords: CR، پاسخ کامل; AA, aplastic anemia; BM, bone marrow; CR, complete response; EBI3, Epstein–Barr virus-induced protein 3; IFN-γ, interferon-γ; IL, interleukin; IST, immunosuppressive therapy; Non-SAA, non-severe AA; PB, peripheral blood; PBMCs, peripheral blood mononuclea
Keywords: CR، پاسخ کامل; balloon occlusion; infusions; intra-arterial; hemodialysis solutions; urinary bladder neoplasmsBOAI, balloon occluded arterial infusion; CR, complete response; HD, hemodialysis; LN, lymph node; OMC, Osaka Medical College; UC, urothelial carcinoma
Keywords: CR، پاسخ کامل; Acute myeloid leukemia; Azacitidine; Decitabine; Hematopoietic stem cell transplant; Maintenance therapy; Panobinostat; Sorafenib; QuizartinibAML, acute myeloid leukemia; CIBMTR, center for international blood and marrow transplant; CR, complete response;
Keywords: CR، پاسخ کامل; liver cancer; transplant; radiofrequency ablation; trans-arterial chemoembolization; targeted therapyAASLD, American Association for the Study of Liver Diseases; CR, complete response; CT, computed tomography; DWI, diffusion weighted imaging; EASL, Europe
Keywords: CR، پاسخ کامل; Clinical trials; Biomarkers; Diarrhea; Notch signaling; Monoclonal antibodies (mAbs); γ-Secretase inhibitorsADAM, a disintegrin and metalloproteases; CR, complete response; CSCs, cancer stem cells; DLL, Delta-like ligand; DLT, dose limiting toxicity; EDTA
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
Keywords: CR، پاسخ کامل; mycobacterium bovis; administration and dosage; urinary bladder neoplasms; quality of life1/2D, half dose; 1/3D, one-third dose; 1/6D, one-sixth dose; AE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CUETO,
Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma
Keywords: CR، پاسخ کامل; A, active; AbsEmax, absolute maximal enhancement; ADC, apparent diffusion coefficient; CR, complete response; CT, computed tomography; DCE-MRI, dynamic contrast enhanced MRI; DWI, diffusion weighted imaging; EPI, echo planar imaging; FS, fat suppressed; I
Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond—A Comprehensive Review of the Current Literature
Keywords: CR، پاسخ کامل; urinary bladder; urothelium; carcinoma; drug therapy; salvage therapyBSC, best supportive care; CR, complete response; EGFR, epidermal growth factor receptor; GC, gemcitabine and cisplatin; Her, human epidermal growth factor receptor; MTX, methotrexate; M
In Vitro and In Vivo Experiments on Electrochemotherapy for Bladder Cancer
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; urothelium; electrochemotherapy; mitomycin; cisplatinCIS, cisplatin; CR, complete response; EP, electroporation; IC50, 50% inhibitory concentration; MMC, mitomycin C; PR, partial response; TURBT, transurethral bladder tumor rese
Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials
Keywords: CR، پاسخ کامل; cutaneous lymphoma; low-dose total skin electron beam therapy; radiotherapy; T-cell lymphoma; total skin electron beam therapyAE, adverse event; CR, complete response; DOCB, duration of clinical benefit; DOR, duration of response; MF, mycosis fungoides; m
Pazopanib as Third Line Therapy for Metastatic Renal Cell Carcinoma: Clinical Efficacy and Temporal Analysis of Cytokine Profile
Keywords: CR، پاسخ کامل; kidney neoplasms; cytokines; pazopanib; biological markers; mortalityCFSE, carboxyfluorescein succinimidyl ester; CR, complete response; DOT2, therapy duration in second line setting; HGF, hepatocyte growth factor; IL, interleukin; mRCC, metastatic renal
Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; BCG vaccine; treatment failure; Mycobacterium phlei; nucleic acidsAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; DFS, disease-free survival; ITT, intent to treat; MCNA, Mycobacte
Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2 1
Keywords: CR، پاسخ کامل; AE, adverse event; BSAP, bone-specific alkaline phosphatase; CBR, clinical benefit rate; CR, complete response; CTX, C-terminal cross-linking telopeptide of type 1 collagen; HER2, human epidermal growth factor receptor 2; HR, hazard ratio; NIP, noninfecti
Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy
Keywords: CR، پاسخ کامل; ALT, alanine aminotransferase; CHB, chronic hepatitis B; CR, complete response; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HC, healthy control; IC, inactive carrier; IFN, interferon; IL, interleukin; IT, immunotolerant; LdT, telbivudine; NCR, n
Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guérin Treatment Failure
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; intravesical administration; therapies; investigational; paclitaxel; nanotechnologyBCG, bacillus Calmette-Guérin; CFS, cystectomy-free survival; CIS, carcinoma in situ; CR, complete response; MDD, maximal deliverable dose; nab,
Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; drug therapy; body temperature changes; BCG vaccine; neoplasm recurrence; localAE, adverse event; BCG, bacillus Calmette-Guérin; CHT, chemohyperthermia; CIS, carcinoma in situ; CR, complete response; EPI, epirubicin; MMC, mitomy
Raltitrexed-based chemotherapy for advanced colorectal cancer
Keywords: CR، پاسخ کامل; Raltitrexed; 5-fluorouracil; Chemotherapy; Advanced colorectal cancer; Meta-analysisCI, Confidence interval; CR, Complete response; DCR, Disease control rate; HR, Hazard ratio; ORR, Overall response rate; PD, Progression disease; PR, Partial response; RR,
Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis
Keywords: CR، پاسخ کامل; 5FU, Fluorouracil; AJCC, American Joint Committee on Cancer; BRAF, v-rafmurine sarcoma viral oncogene homolog B1; CR, complete response; CRC, colorectal cancer; EGFR, epidermal growth factor receptor; GDP, guanosinediphosphate; GTP, guanosine triphosphate
Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma
Keywords: CR، پاسخ کامل; hepatocellular carcinoma (HCC); trans-arterial chemoembolization (TACE); trans-arterial radiotherapy (TART); drug eluting bead (DEB); trans-arterial embolization (TAE)AFP, alpha feto protein; CR, complete response; HAIC, hepatic artery infusion chemothera
Effectiveness of a novel herbal agent MB-6 as a potential adjunct to 5-fluoracil–based chemotherapy in colorectal cancer
Keywords: CR، پاسخ کامل; Herbal medicine; BALB/c mice; Metastatic colorectal cancer; MB-6; Progression-free survival; Overall survival; TolerabilityACF, aberrant crypt foci; AE, adverse effects; CEA, carcinoembryonic antigen; CR, complete response; CRC, colorectal cancer; DMH, 1,
Evaluation of digital images for identification and characterization of monoclonal immunoglobulins by immunofixation
Keywords: CR، پاسخ کامل; LR, Low Resolution; HR, High Resolution; IFX, Immunofixation; SPE, Serum Protein Electrophoresis; MM, Multiple Myeloma; CR, Complete Response; VGPR, Very Good Partial Response; MGUS, Monoclonal Gammopathy of Undetermined Significance; OS, Overall Survival
A Prospective Comparative Study of Intravesical Bacillus Calmette-Guérin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; BCG vaccine; BCG Connaught; treatment outcome; JapanBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; NMIBC, nonmuscle invasive bladder cancer; RFS, recurrence-free survival; TURBT, transurethral rese
Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure
Keywords: CR، پاسخ کامل; urinary bladder; urinary bladder neoplasms; BCG vaccine; treatment failure; gemcitabineBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonMIBC; NR, n
Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer
Keywords: CR، پاسخ کامل; interferons; genetic therapy; urinary bladder neoplasmsAE, adverse event; AWD, alive with disease; BCG, bacillus Calmette-Guérin; CR, complete response; DLT, dose limiting toxicity; IFN, interferon; LLOQ, lower limit of quantitation; NED, no evidence of d
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients : Results from the OVCAD study
Keywords: CR، پاسخ کامل; CR, complete response; PR, partial recurrence; PD, progression of disease; SD, stable disease; OS, overall survival; PFS, progression free survival; HR, hazard ratio; RTM, residual tumor mass; CC, complete cytoreduction; OR, odds ratio; CI, confidence int
A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
Keywords: CR، پاسخ کامل; ASCO, American Society of Clinical Oncology; BBB, blood brain barrier; BM, brain metastases; CNS, central nervous system; CR, complete response; ECOG, Eastern Cooperative Oncology Group; FDA, Food and Drug Administration; HER, human epidermal growth facto
Acitretin for the treatment of cutaneous T-cell lymphoma
Keywords: CR، پاسخ کامل; acitretin; adjuvant; cutaneous T-cell lymphoma; mycosis fungoides; response; retinoid; therapyBSA, body surface area; CR, complete response; CTCL, cutaneous T-cell lymphoma; MF, mycosis fungoides; PR, partial response; PR1, partial response, >50% improvem
A simplified regimen for focal radiofrequency ablation of Barrett's mucosa: a randomized multicenter trial comparing two ablation regimens
Keywords: CR، پاسخ کامل; BE, Barrett's esophagus; CR, complete response; ER, endoscopic resection; FICE, Fuji intelligent chromoendoscopy; IM, intestinal metaplasia; IQR, interquartile range; NBI, narrow band imaging; RFA, radiofrequency ablation
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma
Keywords: CR، پاسخ کامل; ASCT, autologous stem cell transplantation; a.U., arbitrary units; A, artery; CR, complete response; DCE-MRI, dynamic contrast enhanced MRI; IMWG, International Myeloma Working Group; ISS, international staging system; MPNST, malignant peripheral nerve sh
Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Keywords: CR، پاسخ کامل; Breast cancer; Human epidermal growth factor receptor; Lapatinib; Targeted therapy; TrastuzumabAMP, adenosine monophosphate; CBR, clinical benefit rate; CI, confidence interval; CR, complete response; EGFR, epidermal growth factor receptor; ER, estrogen r
MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer
Keywords: CR، پاسخ کامل; ABCB1, adenosine triphosphate (ATP); ATP, adenosine triphosphate; CR, complete response; HR, hazard ratio; MDR, multi-drug resistance; NSCLC, non small cell lung cancer; PCR, polymerase chain reaction; PD, progressive disease; Pgp, P-glycoprotein; PR, par
Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases
Keywords: CR، پاسخ کامل; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUC, area under the plasma drug concentration versus time curve; CCRT, concurrent chemoradiotherapy; CR, complete response; G-CSF, granulocyte-colony stimulating factor; 5-HT3, 5-hydroxytript
A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
Keywords: CR، پاسخ کامل; immunotoxins; carcinoma in situ; urinary bladder; administration; intravesical; clinical trials; phase IIAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; EOS, end of study; EpCAM, epithelial cell adhesion mo
Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo
Keywords: CR، پاسخ کامل; cutaneous T-cell lymphoma; denileukin diftitox; lymphoma; mycosis fungoides; placebo; Sézary syndrome; spontaneous remissionAE, adverse event; CCR, clinical complete response; CR, complete response; CTCL, cutaneous T-cell lymphoma; DD, denileukin diftitox
Novel Agents and Approaches for Advanced Renal Cell Carcinoma
Keywords: CR، پاسخ کامل; kidney; carcinoma; renal cell; immunomodulation; antineoplastic agents; clinical trials as topicAE, adverse event; BID, twice daily; CR, complete response; FGFR, fibroblast growth factor receptor; IFN, interferon; mRCC, metastatic renal cell carcinoma; mT
A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guérin Refractory Nonmuscle Invasive Bladder Cancer
Keywords: CR، پاسخ کامل; urinary bladder neoplasms; administration; intravesical; paclitaxel; nanotechnologyBCG, bacillus Calmette-Guérin; CR, complete response; DLT, dose limiting toxicity; MDD, maximum deliverable dose; nab-paclitaxel, nanoparticle albumin-bound paclitaxel; NMI
Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study
Keywords: CR، پاسخ کامل; paclitaxel; hyaluronic acid; administration; intravesical; carcinoma in situ; urinary bladderAEs, adverse events; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; DLT, dose limiting toxicity; HA, hyaluronic acid; NMIBC, nonmus
Successful treatment with a modified bortezomib schedule of weekly and longer intervals for patients with refractory/resistance multiple myeloma
Keywords: CR، پاسخ کامل; NF-κB, nuclear factor kappa B; MM, multiple myeloma; AEs, adverse events; BJP, Bence–Johnes protein; BD, bortezomib and dexamethasone therapy; MP, melphalan pulse predonisolone therapy; PN, peripheral neuropathy; CR, complete response; PR, partial respons
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
Keywords: CR، پاسخ کامل; MCs, mixed cryoglobulinemia syndrome; HCV, hepatitis C virus; CR, complete response; PR, partial response; NR, no responder; MPGN, membranoproliferative glomerulonephritisMixed cryoglobulinemia; Cryoglobulinemic vasculitis; Rituximab; Anti-CD20; Hepatitis
Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified
Keywords: CR، پاسخ کامل; AE, adverse event; CR, complete response; CT, computerized tomography; LVEF, left ventricular ejection fraction; MBC, metastatic breast cancer; MRN complex, MRE11/RAD50/NSB1; OR, overall response; OS, overall survival; PD, progressive disease; PLD, pegyla
Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus
Keywords: CR، پاسخ کامل; CR, complete response; ER, endoscopic resection; ESCC, esophageal squamous cell carcinoma; ESCN, esophageal squamous cell neoplasia; ESD, endoscopic submucosal dissection; HGIN, high-grade intraepithelial neoplasia; HR, high resolution; IEN, intraepitheli
Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution
Keywords: CR، پاسخ کامل; CPK, creatine phosphokinase; CR, complete response; CTCAE, Common Terminology Criteria for Adverse Events; HILP, hyperthermic isolated limb perfusion; IBW, ideal body weight; ILI, isolated limb perfusion; NE, not evaluable; PD, progressive disease; PR, pa
Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status
Keywords: CR، پاسخ کامل; NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; TTP, time to progression; IHC, immunohistochemical; T790M,
Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers
Keywords: CR، پاسخ کامل; ADC, autologous dendritic cells; ALT, alanine aminotransferase; APC, antigen-presenting cells; CHB, chronic hepatitis B; CLT, cytotoxic T lymphocyte; CR, complete response; DC, dendritic cell; DMSO, dimethyl sulfoxide; DNA, deoxyribonucleic acid; FACS, fl
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Keywords: CR، پاسخ کامل; cancer immunotherapy; CPG oligodeoxynucleotides; cutaneous T-cell lymphoma; immunotherapy; PF-3512676; Toll-like receptor 9AE, adverse event; CAILS, Composite Assessment of Index Lesion Severity; CR, complete response; CTCL, cutaneous T-cell lymphoma; DC,
Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents
Keywords: CR، پاسخ کامل; EGFR inhibitors; Combination regimen; Drug interaction; Pharmacokinetics; Pharmacodynamics; Drug sequenceABC, ATP binding cassette; AUC, area under the curve; CR, complete response; Cmax, maximum plasma concentration; EGFR, epidermal growth factor recepto
Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
Keywords: CR، پاسخ کامل; basal cell carcinoma; bleomycin; chemotherapy; fluorouracil; interferon; intralesional; keratoacanthoma; methotrexate; squamous cell carcinomaBCC, basal cell carcinoma; CR, complete response; 5FU, 5-fluoruracil; KA, keratoacanthoma; MTX, methotrexate; NMS
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma
Keywords: CR، پاسخ کامل; CR, complete response; CRT, chemoradiotherapy; RTOG, Radiation Therapy Oncology Group7